Evidence map›Paper›PMID 27300758›Full record

ArticlePloS one2016

Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients.

Anne M L Jansen, Marije A Geilenkirchen, Tom van Wezel, Shantie C Jagmohan-Changur, Dina Ruano, Heleen M van der Klift, Brendy E W M van den Akker, Jeroen F J Laros, Michiel van Galen, Anja Wagner and 8 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Anne M L JansenDepartment of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Marije A GeilenkirchenDepartment of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Tom van WezelDepartment of Pathology, Leiden University Medical Centre, Leiden, The Netherlands.
Shantie C Jagmohan-ChangurDepartment of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Dina RuanoDepartment of Pathology, Leiden University Medical Centre, Leiden, The Netherlands.
Heleen M van der KliftDepartment of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Brendy E W M van den AkkerDepartment of Pathology, Leiden University Medical Centre, Leiden, The Netherlands.
Jeroen F J LarosDepartment of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Michiel van GalenDepartment of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Anja WagnerDepartment of Clinical Genetics, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Tom G W LetteboerDepartment of Medical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands.
Encarna B Gómez-GarcíaDepartment of Clinical Genetics, University Hospital Maastricht, Maastricht, The Netherlands.
Carli M J TopsDepartment of Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Hans F VasenDepartment of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.
Peter DevileeDepartment of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Frederik J HesDepartment of Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Hans MorreauDepartment of Pathology, Leiden University Medical Centre, Leiden, The Netherlands.
Juul T WijnenDepartment of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Leiden University · NLMaastricht University Medical Centre · NLUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsLynch Syndrome (LS) is caused by pathogenic germline variants in one of the mismatch repair (MMR) genes. However, up to 60% of MMR-deficient colorectal cancer cases are categorized as suspected Lynch Syndrome (sLS) because no pathogenic MMR germline variant can be identified, which leads to difficulties in clinical management. We therefore analyzed the genomic regions of 15 CRC susceptibility genes in leukocyte DNA of 34 unrelated sLS patients and 11 patients with MLH1 hypermethylated tumors with a clear family history.

methodsUsing targeted next-generation sequencing, we analyzed the entire non-repetitive genomic sequence, including intronic and regulatory sequences, of 15 CRC susceptibility genes. In addition, tumor DNA from 28 sLS patients was analyzed for somatic MMR variants.

resultsOf 1979 germline variants found in the leukocyte DNA of 34 sLS patients, one was a pathogenic variant (MLH1 c.1667+1delG). Leukocyte DNA of 11 patients with MLH1 hypermethylated tumors was negative for pathogenic germline variants in the tested CRC susceptibility genes and for germline MLH1 hypermethylation. Somatic DNA analysis of 28 sLS tumors identified eight (29%) cases with two pathogenic somatic variants, one with a VUS predicted to pathogenic and LOH, and nine cases (32%) with one pathogenic somatic variant (n = 8) or one VUS predicted to be pathogenic (n = 1).

conclusionsThis is the first study in sLS patients to include the entire genomic sequence of CRC susceptibility genes. An underlying somatic or germline MMR gene defect was identified in ten of 34 sLS patients (29%). In the remaining sLS patients, the underlying genetic defect explaining the MMRdeficiency in their tumors might be found outside the genomic regions harboring the MMR and other known CRC susceptibility genes.

Indexed as

DNA MethylationDNA Mismatch RepairGene Expression Regulation, NeoplasticCohort StudiesColonColorectal NeoplasmsColorectal Neoplasms, Hereditary NonpolyposisGerm-Line MutationHumansLeukocytesMiddle AgedMutL Protein Homolog 1RectumMutL Protein Homolog 1

Identifiers

PMID27300758
PMCPMC4907507
OpenAlexW2433099156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.